Neuromuscular disorders in left ventricular hypertrabeculation/noncompaction

Current Pharmaceutical Design

Volumn 16, Issue 26, 2010, Pages 2895-2904

  Finsterer, Josef ^a   Stöllberger, Claudia ^a   Fazio, Giovanni ^b  

^a KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Echocardiography; Embolism; Hypertrabeculation; Myopathy; Neuropathy; Peripheral nervous system; Spongy myocardium; Stroke; Systolic function

Indexed keywords

ADENOSINE MONOPHOSPHATE DEAMINASE;

ADENOSINE MONOPHOSPHATE DEAMINASE DEFICIENCY; ARTICLE; BARTH SYNDROME; BECKER MUSCULAR DYSTROPHY; CARDIOLOGIST; DISEASE ASSOCIATION; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DYSBREVINOPATHY; HEART ARRHYTHMIA; HEREDITARY NEUROPATHY CMT1A; HUMAN; INCLUSION BODY MYOSITIS; LAMINOPATHY; LEFT VENTRICULAR HYPERTRABECULATION; MYOTONIC DYSTROPHY; NEUROMUSCULAR DISEASE; NEUROPATHY; PATHOGENESIS; PATIENT REFERRAL; PRIORITY JOURNAL; PROGNOSIS; ZASPOPATHY;

EID: 78649960584     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161210793176437     Document Type: Article

References (98)

1. Finsterer J, Stöllberger C. Primary myopathies and the heart. Scand Cardiovasc J 2008; 42: 9-24.
2. Stöllberger C, Finsterer J, Blazek G, Bittner RE. Left ventricular non-compaction in a patient with becker's muscular dystrophy. Heart 1996; 76: 380.
3. Finsterer J, Stöllberger C, Blazek G. Neuromuscular implications in left ventricular hypertrabeculation/noncompaction. Int J Cardiol 2006; 110: 288-300.
4. Stöllberger C, Finsterer J, Valentin A, Blazek G, Tscholakoff D. Isolated left ventricular abnormal trabeculation in adults is associated with neuromuscular disorders. Clin Cardiol 1999; 22: 119-23.
5. Stöllberger C, Finsterer J, Blazek G. Isolated left ventricular abnormal trabeculation is a cardiac manifestation of neuromuscular disorders. Cardiology 2000; 94: 72-6.
6. Stöllberger C, Blazek G, Wegner C, Winkler-Dworak M, Finsterer J. Neuromuscular and cardiac comorbidity determines survival in 140 patients with left ventricular hypertrabeculation/noncompaction. Int J Cardiol 2010; (in press).
7. Stöllberger C, Finsterer J, Blazek G. Left ventricular hypertrabeculation/noncompaction and association with additional cardiac abnormalities and neuromuscular disorders. Am J Cardiol 2002; 90: 899-902
8. Bleyl SB, Mumford BR, Thompson V, et al. Neonatal, lethal noncompaction of the left ventricular myocardium is allelic with Barth syndrome. Am J Hum Genet 1997; 61: 868-72
9. Finsterer J, Stöllberger C. Hypertrabeculated left ventricle in mitochondriopathy. Heart 1998; 80: 632
10. Ichida F, Tsubata S, Bowles KR, et al. Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome. Circulation 2001; 103: 1256-63
11. Finsterer J, Stöllberger C, Wegmann R, Jarius C, Janssen B. Left ventricular hypertrabeculation in myotonic dystrophy type 1. Herz 2001; 26: 287-90
12. Vatta M, Mohapatra B, Jimenez S, et al. Mutations in cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. J Am Coll Cardiol 2003; 42: 2014-27
13. Hermida-Prieto M, Monserrat L, Castro-Beiras A, et al. Familial dilated cardiomyopathy and isolated left ventricular noncompaction associated with lamin A/C gene mutations. Am J Cardiol 2004; 94: 50-4
14. Finsterer J, Gelpi E, Stöllberger C. Left ventricular hypertrabeculation/noncompaction as a cardiac manifestation of Duchenne muscular dystrophy under non-invasive positive-pressure ventilation. Acta Cardiol 2005; 60: 445-8
15. Finsterer J, Schoser B, Stöllberger C. Myoadenylate-deaminase gene mutation associated with left ventricular hypertrabeculation/non-compaction. Acta Cardiol 2004; 59: 453-6
16. Corrado G, Checcarelli N, Santarone M, Stollberger C, Finsterer J. Left ventricular hypertrabeculation/noncompaction with PMP22 duplication-based Charcot-Marie-Tooth disease type 1A. Cardiology 2006; 105: 142-5
17. Wahbi K, Meune C, Bassez G, et al. Left ventricular non-compaction in a patient with myotonic dystrophy type 2. Neuromuscul Disord 2008; 18: 331-3
18. Finsterer J, Stöllberger C, Höftberger R. Left ventricular hypertrabeculation/noncompaction in hereditary inclusion body myopathy. Int J Cardiol 2009; (in press)
19. Bleyl SB, Mumford BR, Brown-Harrison MC, et al. Xq28-linked noncompaction of the left ventricular myocardium: Prenatal diagnosis and pathologic analysis of affected individuals. Am J Med Genet 1997; 72: 257-65
20. Finsterer J, Stöllberger C, Schubert B. Acquired left ventricular hypertrabeculation/noncompaction in mitochondriopathy. Cardiology 2004; 102: 228-30
21. Finsterer J, Stöllberger C, Gaismayer K, Janssen B. Acquired noncompaction in Duchenne muscular dystrophy. Int J Cardiol 2006; 106: 420-1
22. Finsterer J, Stöllberger C, Wegmann R, Janssen LA. Acquired left ventricular hypertrabeculation/noncompaction in myotonic dystrophy type 1. Int J Cardiol 2009; 137: 310-3
23. Finsterer J, Stöllberger C, Schubert B. Acquired left ventricular noncompaction as a cardiac manifestation of neuromuscular disorders. Scand Cardiovasc J 2008; 42: 25-30
24. Finsterer J. Cardiogenetics, neurogenetics, and pathogenetics of left ventricular hypertrabeculation/noncompaction. Pediatr Cardiol 2009; 30: 659-81
25. Donati MA, Malvagia S, Pasquini E, et al. Barth syndrome presenting with acute metabolic decompensation in the neonatal period. J Inherit Metab Dis 2006; 29: 684
26. Mazzocco MM, Kelley RI. Preliminary evidence for a cognitive phenotype in Barth syndrome. Am J Med Genet 2001; 102: 372-8
27. Pignatelli RH, McMahon CJ, Dreyer WJ, et al. Clinical characterization of left ventricular noncompaction in children: a relatively common form of cardiomyopathy. Circulation 2003; 108: 2672-8
28. Barth PG, Valianpour F, Bowen VM, et al. X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): an update. Am J Med Genet 2004; 126A: 349-54
29. Adwani SS, Whitehead BF, Rees PG, et al. Heart transplantation for Barth syndrome. Pediatr Cardiol 1997; 18: 143-5
30. Kuijpers TW, Maianski NA, Tool AT, et al. Neutrophils in Barth syndrome (BTHS) avidly bind annexin-V in the absence of apoptosis. Blood 2004; 103: 3915-23
31. Yen TY, Hwu WL, Chien YH, et al. Acute metabolic decompensation and sudden death in Barth syndrome: report of a family and a literature review. Eur J Pediatr 2008; 167: 941-4
32. Marziliano N, Mannarino S, Nespoli L, et al. Barth syndrome associated with compound hemizygosity and heterozygosity of the TAZ and LDB3 genes. Am J Med Genet 2007; 143A: 907-15
33. Chen R, Tsuji T, Ichida F, et al. Noncompaction study collaborators. Mutation analysis of the G4.5 gene in patients with isolated left ventricular noncompaction. Mol Genet Metab 2002; 77: 319-25
34. Kenton AB, Sanchez X, Coveler KJ, et al. Isolated left ventricular noncompaction is rarely caused by mutations in G4.5, alphadystrobrevin and FK Binding Protein-12. Mol Genet Metab 2004; 82: 162-6
35. Scaglia F, Towbin JA, Craigen WJ, et al. Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease. Pediatrics 2004; 114: 925-31
36. Spencer CT, Bryant RM, Day J, et al. Cardiac and clinical phenol type in Barth syndrome. Pediatrics 2006; 118: e337-46
37. Xing Y, Ichida F, Matsuoka T, et al. Genetic analysis in patients with left ventricular noncompaction and evidence for genetic heterogeneity. Mol Genet Metab 2006; 88: 71-7
38. Yaplito-Lee J, Weintraub R, Jamsen K, Chow CW, Thorburn DR, Boneh A. Cardiac manifestations in oxidative phosphorylation disorders of childhood. J Pediatr 2007; 150: 407-11
39. Cortez-Dias N, Varela MG, Sargento L, et al. Left ventricular non-compaction: a new mutation predisposing to reverse remodeling? Rev Port Cardiol 2009; 28: 185-94
40. Kohli SK, Pantazis AA, Shah JS, et al. Diagnosis of left-ventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria? Eur Heart J 2008; 29: 89-95
41. Chang B, Momoi N, Shan L, et al. Noncompaction study collaborators. Gonadal mosaicism of a TAZ (G4.5) mutation in a Japanese family with Barth syndrome and left ventricular noncompaction. Mol Genet Metab 2010; (in press)
42. Finsterer J. Mitochondriopathies. Eur J Neurol 2004; 11: 163-86
43. Finsterer J. Overview on visceral manifestations of mitochondrial disorders. Neth J Med 2006; 64: 61-71
44. Finsterer J, Harbo HF, Baets J, et al. EFNS guidelines on the molecular diagnosis of mitochondrial disorders. Eur J Neurol 2009; 16: 1255-64
45. Finsterer J, Stöllberger C, Feichtinger H. Noncompaction and endocarditis in suspected mitochondrial disorder. Int J Cardiol 2008; 123: e45-7
46. Finsterer J, Kopsa W, Stöllberger C. Apical hypertrophic cardiomyopathy in encephalomyopathy. J Cardiovasc Med (Hagerstown) 2007; 8: 1069-72
47. Finsterer J, Stöllberger C. Postpartum syncope and noncompaction in suspected encephalomyopathy. South Med J 2006; 99: 1304-5
48. Finsterer J, Stöllberger C, Gelpi E. Successful heart failure therapy in mitochondrial disorder with noncompaction cardiomyopathy. Int J Cardiovasc Imaging 2006; 22: 393-8
49. Finsterer J, Stöllberger C, Feichtinger H. Non-compaction on echocardiography and autopsy. Acta Cardiol 2003; 58: 165-8
50. Finsterer J, Stöllberger C. Hypertrabeculated left ventricle in mitochondriopathy. Heart 1998; 80: 632
51. Finsterer J, Bittner R, Bodingbauer M, Eichberger H, Stöllberger C, Blazek G. Complex mitochondriopathy associated with 4 mtDNA transitions. Eur Neurol 2000; 44: 37-41
52. Finsterer J, Stöllberger C, Kopsa W, Jaksch M. Wolff-Parkinson White syndrome and isolated left ventricular abnormal trabeculation as a manifestation of Leber's hereditary optic neuropathy. Can J Cardiol 2001; 17: 464-6
53. Finsterer J, Stöllberger C. LMX1B 17-bp deletion and A3243G mtDNA transition in a previously described patient. Eur Neurol 2003; 49: 186-7
54. Ware SM, El-Hassan N, Kahler SG, et al. Infantile cardiomyopathy caused by a mutation in the overlapping region of mitochondrial ATPase 6 and 8 genes. J Med Genet 2009; 46: 308-14
55. Tang S, Batra A, Zhang Y, Ebenroth ES, Huang T. Left ventricular noncompaction is associated with mutations in the mitochondrial genome. Mitochondrion 2010; 10(4): 350-7
56. Davili Z, Johar S, Hughes C, Kveselis D, Hoo J. Succinate dehydrogenase deficiency associated with dilated cardiomyopathy and ventricular noncompaction. Eur J Pediatr 2007; 166: 867-70
57. Stöllberger C, Finsterer J, Blazek G. Left ventricular hypertrabeculation/ noncompaction and association with additional cardiac abnormalities and neuromuscular disorders. Am J Cardiol 2002; 90: 899-902
58. Edston E, Perskvist N. Histiocytoid cardiomyopathy and ventricular non-compaction in a case of sudden death in a female infant. Int J Legal Med 2009; 123(1): 47-53
59. Finsterer J. Histiocytoid cardiomyopathy: a mitochondrial disorder. Clin Cardiol 2008; 31: 225-7
60. Limongelli G, Tome-Esteban M, Dejthevaporn C, Rahman S, Hanna MG, Elliott PM. Prevalence and natural history of heart disease in adults with primary mitochondrial respiratory chain disease. Eur J Heart Fail 2010; 12: 114-21
61. Selcen D, Engel AG. Mutations in ZASP define a novel form of muscular dystrophy in humans. Ann Neurol 2005; 57: 269-76
62. Arimura T, Hayashi T, Terada H, et al. A Cypher/ZASP mutation associated with dilated cardiomyopathy alters the binding affinity to protein kinase C. J Biol Chem 2004; 279: 6746-52
63. Zhou Q, Chu PH, Huang C, et al. Ablation of Cypher, a PDZ-LIM domain Z-line protein, causes a severe form of congenital myopathy. J Cell Biol 2001; 155: 605-12
64. Turner C, Hilton-Jones D. The myotonic dystrophies: diagnosis and management. J Neurol Neurosurg Psychiatry 2010: 81: 358-67
65. Wheeler TM, Thornton CA. Myotonic dystrophy: RNA-mediated muscle disease. Curr Opin Neurol 2007; 20: 572-6
66. Finsterer J, Stölberger C, Kopsa W. Noncompaction in myotonic dystrophy type 1 on cardiac MRI. Cardiology 2005; 103: 167-8
67. Sá MI, Cabral S, Costa PD, et al. Cardiac involveent in type 1 myotonic dystrophy. Rev Port Cardiol 2007; 26: 829-40
68. Jones KJ, Compton AG, Yang N, et al. Deficiency of the syntrophins and alpha-dystrobrevin in patients with inherited myopathy. Neuromuscul Disord 2003; 13: 456-67
69. Sjö A, Magnusson KE, Peterson KH. Association of alpha dystrobrevin with reorganizing tight junctions. J Membr Biol 2005; 203: 21-30
70. Benedetti S, Bertini E, Iannaccone S, et al. Dominant LMNA mutations can cause combined muscular dystrophy and peripheral neuropathy. J Neurol Neurosurg Psychiatry 2005; 76: 1019-21
71. Filesi I, Gullotta F, Lattanzi G, et al. Alterations of nuclear envelope and chromatin organization in mandibuloacral dysplasia, a rare form of laminopathy. Physiol Genomics 2005; 23: 150-8
72. Rankin J, Auer-Grumbach M, Bagg W, et al. Extreme phenotypic diversity and nonpenetrance in families with the LMNA gene mutation R644C. Am J Med Genet 2008; 146A: 1530-42
73. Miner JH. Laminins and their roles in mammals. Microsc Res Technol 2008; 71: 349-56
74. Hermida-Prieto M, Monserrat L, Castro-Beiras A, et al. Familial dilated cardiomyopathy and isolated left ventricular noncompaction associated with lamin A/C gene mutations. Am J Cardiol 2004; 94: 50-4
75. Finsterer J, Stöllberger C. Spontaneous left ventricular hypertrabeculation in dystrophin duplication based Becker's muscular dystrophy. Herz 2001; 26: 477-81
76. Finsterer J, Stöllberger C, Feichtinger H. Noncompaction in Duchenne muscular dystrophy: frustrated attempt to create a compensatory left ventricle? Cardiology 2006; 105: 223-5
77. Dalton JC, Ranum LPW, Day JW. Myotonic Dystrophy Type 2. 2006 Sep 21 updated 2007 Apr 23]. In: Pagon RA, Bird TC, Dolan CR, Stephens K, editors. GeneReviews Internet]. Seattle (WA): University of Washington, Seattle; 1993-. Available from http: //www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=myot onic-d2
78. Abe M, Higuchi I, Morisaki H, Morisaki T, Osame M. Myoadenylate deaminase deficiency with progressive muscle weakness and atrophy caused by new missense mutations in AMPD1 gene: case report in a Japanese patient. Neuromuscul Disord 2000; 10: 472-7
79. Sabina RL. Myoadenylate deaminase deficiency. A common inherited defect with heterogeneous clinical presentation. Neurol Clin 2000; 18: 185-94
80. Fishbein WN. Primary, secondary, and coincidental types of myoadenylate deaminase deficiency. Ann Neurol 1999; 45: 547-8
81. Rico-Sanz J, Rankinen T, Joanisse DR, et al. Associations between cardiorespiratory responses to exercise and the C34T AMPD1 polymorphism in the HERITAGE family study. Physiol Genomics 2003; 14: 161-6
82. Norman B, Mahnke-Zizelman DK, Vallis A, Sabina RL. Genetic and other determinants of AMP deaminase activity in healthy adult skeletal muscle. J Appl Physiol 1998; 85: 1273-8
83. Dumitru D, Newell-Eggert M. Inclusion body myositis. An electrophysiologic study. Am J Phys Med Rehabil 1990; 69: 2-5
84. Askanas V, Engel WK, Alvarez RB, Frangione B, Ghiso J, Vidal R. Inclusion body myositis, muscle blood vessel and cardiac amyloidosis, and transthyretin Val122Ile allele. Ann Neurol 2000; 47: 544-9
85. Argov Z, Mitrani-Rosenbaum S. The hereditary inclusion body myopathy enigma and its future therapy. Neurotherapeutics 2008; 5: 633-7
86. Hussein A, Schmaltz AA, Trowitzsch E. Isolated abnormality (noncompaction) of the myocardium in 3 children. Klin Padiatr 1999; 211: 175-8
87. Pauli RM, Scheib-Wixted S, Cripe L, Izumo S, Sekhon GS. Ventricular noncompaction and distal chromosome 5q deletion. Am J Med Genet 1999; 85: 419-23
88. Ali SK, Omran AS, Najm H, Godman MJ. Noncompaction of the ventricular myocardium associated with mitral regurgitation and preserved ventricular systolic function. J Am Soc Echocardiogr 2004; 17: 87-90
89. Hofer M, Stöllberger C, Finsterer J. Acquired noncompaction associated with myopathy. Int J Cardiol 2007; 121: 296-7
90. Stöllberger C, Blazek G, Winkler-Dworak M, Finsterer J. Cardiac and neuromuscular implications of left bundle branch block in left ventricular hypertrabeculation/noncompaction. Can J Cardiol 2009; 25: e82-5
91. Stöllberger C, Blazek G, Winkler-Dworak M, Finsterer J. Atrial fibrillation in left ventricular noncompaction with and without neuromuscular disorders is associated with a poor prognosis. Int J Cardiol 2009; 133: 41-5
92. Stöllberger C, Finsterer J. Septal hypertrabeculation/noncompaction: cardiac and neurologic implications. Int J Cardiol 2009; 132: 173-5
93. Stöllberger C, Kopsa W, Tscherney R, Finsterer J. Diagnosing left ventricular noncompaction by echocardiography and cardiac magnetic resonance imaging and its dependency on neuromuscular disorders. Clin Cardiol 2008; 31: 383-7
94. Stöllberger C, Blazek G, Winkler-Dworak M, Finsterer J. In and outpatients with noncompaction: differences in cardiac and neuromuscular co-morbidity. Int J Cardiol 2010; 140: 108-11
95. Stöllberger C, Blazek G, Winkler-Dworak M, Finsterer J. Sex differences in left ventricular noncompaction in patients with and without neuromuscular disorders. Rev Esp Cardiol 2008; 61: 130-6
96. Finsterer J, Stollberger C, Mölzer G, Winkler-Dworak M, Blazek G. Cerebrovascular events in left ventricular hypertrabecula tion/noncompaction with and without myopathy. Int J Cardiol 2008; 130: 344-8
97. Stöllberger C, Winkler-Dworak M, Blazek G, Finsterer J. Prognosis of left ventricular hypertrabeculation/noncompaction is dependent on cardiac and neuromuscular comorbidity. Int J Cardiol 2007; 121: 189-93
98. Stöllberger C, Winkler-Dworak M, Blazek G, Finsterer J. Cardiologic and neuromuscular co-morbidity influences mortality of patients with left ventricular hypertrabeculation/noncompaction: comparison with the Austrian general population. Acta Cardiol 2007; 62: 1-5.